Provided by Tiger Trade Technology Pte. Ltd.

Evogene

0.4806
-0.0214-4.26%
Volume:41.71K
Turnover:20.57K
Market Cap:7.59M
PE:-0.53
High:0.5095
Open:0.5000
Low:0.4800
Close:0.5020
52wk High:1.50
52wk Low:0.3700
Shares:15.80M
Float Shares:14.46M
Volume Ratio:0.67
T/O Rate:0.29%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.9012
EPS(LYR):-1.0776
ROE:-182.75%
ROA:-37.80%
PB:-2.31
PE(LYR):-0.45

Loading ...

Evogene to Release Q2 2026 Financial Results

Reuters
·
Jul 30

Evogene, ELEO Collaborate to Develop Oral Small-molecule PCSK9 Inhibitors for Hyperlipidemia

Reuters
·
Jul 22

Evogene Expands ATM Offering as Shareholder Activism Escalates

TIPRANKS
·
Jul 18

Agplenus Launches AI Model to Predict Antifungal Potency, Expands Chempass AI for Ag Platform

Reuters
·
Jul 15

Evogene, BCDD announces strategic joint initiative

TIPRANKS
·
Jul 08

Evogene Partners with Tel Aviv University Drug Discovery Center on Ai-driven Small-molecule R&D

Reuters
·
Jul 08

Evogene achieves integration of agentic systems with ChemPass AI platform

TIPRANKS
·
Jun 24

Evogene, Google Cloud Integrate Agentic AI into Chempass Platform in Expanded Collaboration

Reuters
·
Jun 24

Evogene Sets Up $2.9 Million At-the-Market Share Offering With A.G.P.

TIPRANKS
·
Jun 12

Evogene enters ATM equity sales agreement for up to $2.93 million offering

Reuters
·
Jun 12

Evogene to present pharma division achievements at BIO International Convention

Reuters
·
Jun 09

Evogene Announces Successful Completion Of Phase 1 Clinical Study Of Bmc128, A Rationally Designed Live Bacterial Product, In Combination With Nivolumab By Its Subsidiary Biomica

Reuters
·
Jun 02

Evogene completes Phase 1 trial of Biomica’s BMC128 plus Bristol-Myers’ Opdivo in advanced solid tumors

Reuters
·
Jun 02

Analysts Are Bullish on These Healthcare Stocks: Evogene (EVGN), NanoViricides (NNVC)

TIPRANKS
·
May 27

Evogene price target lowered to $2.15 from $2.25 at Alliance Global

TIPRANKS
·
May 27

Evogene Earnings Call: AI Momentum vs. Cash Strain

TIPRANKS
·
May 21

Evogene Ltd reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
May 20

Evogene Tightens Focus on AI Small-Molecule Platform as Q1 2026 Revenue Falls

TIPRANKS
·
May 20

Evogene reporta Q1 cont. ops. EPS (60c) vs. (26c) last year

TIPRANKS
·
May 20

Evogene Q1 FY26 net loss widens to USD 5.9 million; revenue drops 87.22% to USD 334,000

Reuters
·
May 20